Centene Corp Files 8-K Current Report

Ticker: CNC · Form: 8-K · Filed: 2025-03-12T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, disclosure, corporate-event

Related Tickers: CNC

TL;DR

Centene (CNC) filed an 8-K on 3/12 for an event on 3/11 - check filing for details.

AI Summary

Centene Corporation filed an 8-K on March 12, 2025, reporting an event that occurred on March 11, 2025. The filing is a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934. No specific details of the event are provided in the header information.

Why It Matters

This filing indicates a material event has occurred for Centene Corporation, requiring public disclosure. Investors should review the full report for details on the nature and impact of this event.

Risk Assessment

Risk Level: low — The provided header information does not contain details of the event, making it impossible to assess the risk level without further context from the full filing.

Key Numbers

001-31826 — SEC File Number (Identifies Centene Corporation's filing with the SEC.)
42-1406317 — IRS Employer Identification No. (Centene Corporation's tax identification number.)

Key Players & Entities

CENTENE CORP (company) — Registrant
0001071739-25-000042 (filing_id) — Accession Number
March 12, 2025 (date) — Date of Report
March 11, 2025 (date) — Date of earliest event reported
7700 Forsyth Boulevard, St. Louis, Missouri 63105 (address) — Principal Executive Offices

FAQ

What specific event triggered this 8-K filing for Centene Corporation?

The provided header information does not specify the event; the full filing must be reviewed for details.

When was the earliest event reported in this filing?

The earliest event reported was on March 11, 2025.

What is Centene Corporation's principal executive office address?

Centene Corporation's principal executive offices are located at 7700 Forsyth Boulevard, St. Louis, Missouri 63105.

What is the SEC file number for Centene Corporation?

Centene Corporation's SEC file number is 001-31826.

Under which section of the Securities Exchange Act is this report filed?

This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

From the Filing

0001071739-25-000042.txt : 20250312 0001071739-25-000042.hdr.sgml : 20250312 20250311210851 ACCESSION NUMBER: 0001071739-25-000042 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250312 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20250312 DATE AS OF CHANGE: 20250311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 25729746 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 cnc-20250312.htm 8-K cnc-20250312 0001071739 false 0001071739 2025-03-12 2025-03-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: ( 314 ) 725-4477 (Former Name or Former Address, if Changed Since Last Report): N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ITEM 7.01 REGULATION FD DISCLOSURE Centene Corporation will be presenting at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025, at 2:30 p.m. EDT. A simultaneous live audio webcast of the presentation on March 12 will be available at https://event.webcasts.com/starthere.jsp?ei=1711439&tp_key=abafa719df&tp_special=8. A webcast replay will be available following the presentation via the Company's website at www.centene.com, under the Investors section. During the presentation, the Company expects to reaffirm its previously issued 2025 adjusted diluted earnings per share (EPS) annual guidance of greater than $7.25. Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures in this Form 8-K as the Company believes that these figures are helpful in allowing investors to more accurately asses